Submit
Contact Us
Submit
Products
Product Overview
Carterra Ultra
Carterra LSA
XT
Carterra LSA
Sensor Chips & Solutions
Kinetics
TM
Analysis Software
Epitope
TM
Analysis Software
AI, ML & In Silico Tools
Testimonials
Applications
Overview
High Throughput Kinetics
Epitope Binning
Fc-Gamma Receptor
GPCR and Transmembrane Proteins
Quantitation
Antibody Epitope Mapping
Therapeutic Areas
Antibody Formats
Proximity-Based Degraders
DNA Encoded Library (DEL)
Kinase Inhibitors
Technology
Carterra HT-SPR™ Technology
SPR Overview
Attend SPR Camp
Testimonials
Frequently Asked Questions
Resources
Application Notes
Webinars and Videos
Podcasts
White Papers
Publications
Brochures & eBook
Posters
Symposia
2025
2024
2023
2022
2019
About Us
Overview
Management Team
Board of Directors
Testimonials
Careers
News
Blog
Events
Contact Us
Support
Inquiries
Customer Login
Application Training Program
Attend SPR Camp
Technical Support Updates
Store
Resource Center
Learn About Carterra and the LSA Platform
Application Note
Increasing FcγR Characterization Throughput for Drug Candidates Using LSA
XT
Application Note
Large-scale characterization of drug candidates against transmembrane receptors using HT-SPR
Application Note
Quantitation of IgG and His-tagged proteins using the Carterra LSA
Application Note
Carterra LSA
XT
characterization of kinase inhibitor selectivity and kinetics
Application Note
Leveraging array-based SPR to profile PROTAC
®
cooperativity
Application Note
Increasing DNA Encoded Library (DEL) Screening Resolution Using HT-SPR
Peer-Reviewed Publication
Science: LY-CoV555, a Rapidly Isolated Potent Neutralizing Antibody, Provides Protection in a Non-Human Primate Model of SARS-CoV-2 Infection
Poster
Increasing DNA Encoded Library Screening Resolution Using HT-SPR
Application Note
High resolution FcRn IC
50
potency measurements using the Carterra
®
LSA
®
platform
Application Note
Profiling antibody polyreactivity and polyspecificity using HT-SPR on the Carterra
®
LSA
®
Webinar
The Transcendence of HT-SPR Technology Across Discovery Platforms and its Impact on Time-to-Clinic
Video • Webinar
FcRn Binding and Therapeutics Antibody Screening
Peer-Reviewed Publication
Absci achieves a breakthrough in AI drug creation
Peer-Reviewed Publication
Healthy humans can be a source of antibodies countering COVID-19
4
5
6
